S0819-Tumor-Annotations | Annotations for A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer
DOI: 10.7937/R0R8-BN93 | Data Citation Required | 53 Views | Analysis Result
Location | Subjects | Size | Updated | ||
---|---|---|---|---|---|
Lung Cancer | Lung | 1,297 | 2024/11/09 |
Summary
This dataset contains image annotations derived from the NCI Clinical Trial “A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer”. This dataset was generated as part of an NCI project to augment TCIA datasets with annotations that will improve their value for cancer researchers and AI developers. For each patient, all scans were reviewed to identify and annotate the clinically relevant time points and sequences/series. Scans were initially annotated by an international team of radiologists holding MBBS degrees or higher, which were then reviewed by US-based board-certified radiologists to ensure accuracy. In a typical patient, all available time points were annotated. Every exam from the first available time point was annotated. One additional time point was annotated for each patient. The clinical data in the NCTN Archive was utilized to help determine the first evidence of disease progression. The first time point demonstrating disease progression was annotated. If that document was not accurate and did not demonstrate disease progression, then later time points were reviewed to assess for disease progression and the first time point demonstrating disease progression was annotated. If there was no evidence of disease progression on any time point, then the last available time point was annotated. Again, every exam from each chosen time point was annotated. For example, if there was a CT and a PET/CT, the PET was annotated along with one CT. If there was an MRI, that was annotated as well. The following annotation rules were followed: At each time point:Annotation Protocol
Important supplementary information and sample code
Data Access
Version 3: Updated 2024/11/09
Improved consistency of StructureSetLabels by correcting series with minor variations and typos. Fixed some seed points that accidentally contained volume calculations and some segmentations which were missing them. Updated seed points to work properly with 3D Slicer’s expectations for fiducial points to make them easier to visualize.
Title | Data Type | Format | Access Points | Subjects | License | |||
---|---|---|---|---|---|---|---|---|
S0819 Annotations - Segmentations, Seed Points and Negative Findings Assessments | RTSTRUCT | DICOM | Download requires NBIA Data Retriever |
1,297 | 2,584 | 20,365 | 20,365 | NCTN/NCORP Data Archive License (Without Collaborative Agreement) |
S0819 Annotation Metadata | Measurement, Classification | CSV | 1,297 | CC BY 4.0 |
Collections Used In This Analysis Result
Title | Data Type | Format | Access Points | Subjects | License | |||
---|---|---|---|---|---|---|---|---|
Original S0819 Images used to create Segmentations and Seed Points | CT, MR, PT | DICOM | Requires NBIA Data Retriever |
1,294 | 2,572 | 2,948 | 607,500 | NCTN/NCORP Data Archive License (Without Collaborative Agreement) |
Original S0819 Images used to create Negative Assessment reports | CT, MR, PT | DICOM | Requires NBIA Data Retriever |
11 | 12 | 15 | 2,465 | NCTN/NCORP Data Archive License (Without Collaborative Agreement) |
Additional Resources For This Dataset
- NCTN/NCORP Data Archive provides the Clinical Data files related to these subjects, and is also where you go to request access to the entire dataset
- Jupyter notebook demonstrating how to use the NBIA Data Retriever Command-Line Interface application and REST API (with authentication) to access these data
- Instructions for Visualizing these data in 3D Slicer
Citations & Data Usage Policy
Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:
Data Citation |
|
Rozenfeld, M., & Jordan, P. (2024). Annotations for A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (S0819-Tumor-Annotations) (Version 3) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/R0R8-BN93 |
Related Publications
Publications by the Dataset Authors
The authors recommended the following as the best source of additional information about this dataset:
Research Community Publications
TCIA maintains a list of publications that leveraged this dataset. If you have a manuscript you’d like to add please contact TCIA’s Helpdesk.
Previous Versions
Version 2: Updated 2024/04/11
Added 1 patient
Title | Data Type | Format | Access Points | Subjects | License | |||
---|---|---|---|---|---|---|---|---|
S0819 Annotations - Segmentations, Seed Points and Negative Findings Assessments | RTSTRUCT, Classification | DICOM | Download requires NBIA Data Retriever |
1,297 | 2,584 | 20,365 | 20,365 | NCTN/NCORP Data Archive License (Without Collaborative Agreement) |
S0819 Annotation Metadata | CSV | 1,297 | CC BY 4.0 |
Version 1: Updated 2024/03/26
Title | Data Type | Format | Access Points | Subjects | License | |||
---|---|---|---|---|---|---|---|---|
S0819 Annotations - Segmentations, Seed Points and Negative Findings Assessments | RTSTRUCT | DICOM | Download requires NBIA Data Retriever |
1,296 | 2,582 | 20,353 | 20,353 | NCTN/NCORP Data Archive License (Without Collaborative Agreement) |
S0819 Annotation Metadata | CSV | 1,296 | CC BY 4.0 |